Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)
BackgroundMultiple myeloma (MM) is a plasma cell malignancy with significant unmet medical needs, particularly in the treatment of relapsed and refractory disease. This study aims to describe the disease characteristics, various treatment regimens, and outcomes among patients with Relapsed/Refractor...
Saved in:
| Main Authors: | Ayman Alhejazi, Ahmad Alhuraiji, Abdulnaser Nourallah, Abdulrahman Alshehri, Binyam Usman, Ghada ElGohary, Hafiz Malhan, Ibraheem Motabi, Khalil Al Farsi, Mohammed Alshuaibi, Mohanad Diab, Mustaqeem Siddiqui, Ruba Yasin Taha, Tarek Abouzeid, Wesam Ahmed, Ahmed Ramadan Ali, Rasha Ghonema, Sana Faysal Elkhazin, Yousra Moussa, Abdullah M. Alrajhi, Magdy Rabea, Yahia Aktham, Nesreen Bawazeer, Ali Ahmed Ali, Mohamed Zahir Chouikrat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1547138/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells
by: Hongjie Wang, et al.
Published: (2024-12-01) -
Subcutaneous administration of isatuximab in patients with multiple myeloma by an on-body delivery system: results of a nurse survey
by: Nuria Sánchez Avello, et al.
Published: (2025-06-01) -
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency
by: F. Jakobs, et al.
Published: (2025-03-01) -
Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia
by: M. V. Solovev, et al.
Published: (2024-12-01) -
Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01)